Hydrocortisone
Brand names: Solu-Cortef, Hydrocortistab
Hydrocortisone is a glucocorticoid (with mineralocorticoid activity) used parenterally in emergencies including adrenal crisis, severe asthma, anaphylaxis as an adjunct and acute severe inflammatory reactions.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It binds glucocorticoid receptors to modulate gene transcription, producing broad anti-inflammatory and immunosuppressive effects, and provides physiological corticosteroid replacement in adrenal insufficiency.
Prescribing in practice
- In suspected adrenal crisis, give parenteral hydrocortisone without delay alongside fluid resuscitation, as treatment is life-saving and should not await confirmatory tests.
- In anaphylaxis it is a slow-onset adjunct only and must not delay intramuscular adrenaline.
- It can cause hyperglycaemia, fluid retention, hypokalaemia and, with repeated use, adrenal suppression that must not be stopped abruptly.
Monitoring
Monitor blood glucose, blood pressure, fluid balance and electrolytes, and the clinical response to treatment.
Counselling the patient
- This steroid is being given urgently to treat a serious reaction or low cortisol level.
- If you take long-term steroids, never stop them suddenly and carry a steroid alert card.
- Tell us if you have an infection, as steroids can mask its signs.
Evidence & guidelines
Parenteral hydrocortisone for adrenal crisis is supported by Society for Endocrinology and NICE guidance.
Reference: NICE; RCUK Anaphylaxis 2021; BTS/SIGN Asthma 2023; APROCCHSS Trial NEJM 2018; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
Hydrocortisone is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.